SEC Info - Opexa Therapeutics, Inc. - ‘8-K’ for 5/16/16

SEC Info℠

Home

Help

Please Sign In

Opexa Therapeutics, Inc. – ‘8-K’ for 5/16/16

On: Wednesday, 5/18/16, at 4:05pm ET · For: 5/16/16 · Accession #: 1354488-16-7543 · File #: 1-33004

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/18/16  Opexa Therapeutics, Inc.          8-K:5       5/16/16    1:58K                                    Issuer Direct/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     30K

This is an HTML Document rendered as filed. [ Alternative Formats ]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): May 16, 2016

OPEXA THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

Texas		001-33004		76-0333165
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

2635 Technology Forest Blvd., The Woodlands, Texas		77381
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (281) 272-9331
N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.07

Submission of Matters to a Vote of Security Holders

The Annual Meeting of Shareholders for Opexa Therapeutics, Inc. was held on May 16, 2016 (the “Annual Meeting”). Four proposals were submitted to shareholders as described in the 2016 Proxy Statement and were approved by shareholders at the Annual Meeting. The proposals and the results of the shareholder votes are as follows.

1. Proposal to elect six directors for one-year terms:

	For		Withheld		Broker Non-Votes

Timothy C. Barabe		1,350,520		149,738		3,439,982
Hans-Peter Hartung		1,058,783		441,475		3,439,982
Gail J. Maderis		1,349,515		150,743		3,439,982
Michael S. Richman		1,349,704		150,554		3,439,982
Scott B. Seaman		1,350,668		149,590		3,439,982
Neil K. Warma		1,339,552		160,706		3,439,982

2. Proposal to approve the Amended and Restated 2010 Stock Incentive Plan:

For				Against				Abstain				Broker Non-Votes
	1,237,868				241,814				20,576				3,439,982

3. Proposal to hold an advisory “say-on-pay” vote on the compensation of the Named Executive Officers:

For				Against				Abstain				Broker Non-Votes
	1,239,707				229,349				31,202				3,439,982

4. Proposal to ratify the appointment of MaloneBailey, LLP as independent auditors for the fiscal year ending December 31, 2016:

For				Against				Abstain				Broker Non-Votes
	4,865,393				59,246				15,601				0

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: May 18, 2016	OPEXA THERAPEUTICS, INC.

	By:	/s/ *Neil K. Warma*
		Neil K. Warma
		President, Chief Executive Officer and Acting Chief Financial Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

	12/31/16
Filed on:	5/18/16
For Period End:	5/16/16	DEF 14A
		List all Filings

↑Top

Filing Submission 0001354488-16-007543 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Opexa Therapeutics, Inc. – ‘8-K’ for 5/16/16

On: Wednesday, 5/18/16, at 4:05pm ET · For: 5/16/16 · Accession #: 1354488-16-7543 · File #: 1-33004

Previous ‘8-K’: ‘8-K’ on / for 5/12/16 · Next: ‘8-K’ on / for 8/11/16 · Latest: ‘8-K’ on 11/20/23 for 11/17/23

Current Report — Form 8-KFiling Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Current Report — Form 8-K
Filing Table of Contents